From April 18, 2024 to June 30, 2024, the company has repurchased 5,436,100 shares, representing 0.93% for CNY 13.01 million. With this, the company has completed the repurchase of 5,436,100 shares, representing 0.93% for CNY 13.01 million under the buyback announced on April 19, 2024.
Qinghai Spring Medicinal Resources Technology Co., Ltd.
Equities
600381
CNE0000017W0
Pharmaceuticals
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
2.29 CNY | -1.29% | +17.44% | -70.38% |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-70.38% | 187M | |
+27.19% | 5.36B | |
-33.59% | 3.4B | |
-2.97% | 2.9B | |
-24.21% | 2.53B | |
-10.11% | 2.27B | |
+43.66% | 1.84B | |
+46.15% | 1.42B | |
+41.90% | 1.38B | |
-13.92% | 1.37B |
- Stock Market
- Equities
- 600381 Stock
- News Qinghai Spring Medicinal Resources Technology Co., Ltd.
- Tranche Update on Qinghai Spring Medicinal Resources Technology Co., Ltd.'s Equity Buyback Plan announced on April 19, 2024.